2026年10月24日 7:30 ET 发布 · 更新于 21 天前 · 1 个来源
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
Wired
·
原始报道
INFERY
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
原文